Pathology Doctors in Nebraska Medicare Details, Address, Contact

164 Pathology doctors found. Showing 161 - 164

Richard J Simmons, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 4021 Avenue B, Scottsbluff, NE 69361 Phone: 308-630-1400    Fax: 308-632-7830

Cris J. Anderson, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 4021 Avenue B, Scottsbluff, NE 69361 Phone: 308-630-1398    Fax: 308-362-7830

Peter W. Schilke, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 4021 Avenue B, Scottsbluff, NE 69361 Phone: 308-630-1398    Fax: 308-632-7830

Randall Williams, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 4021 Avenue B, Scottsbluff, NE 69361 Phone: 308-630-1919

News Archive

Combination treatment lowers risk of ischemic stroke recurrence

Stroke survivors taking a combination of the blood thinner cilostazol with aspirin or clopidogrel had a lower risk of ischemic stroke recurrence than those who received aspirin or clopidogrel alone, according to late breaking science presented at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.

Botox injections decrease drooling in children with neurologic impairments

Ultrasound-guided Botox injections into the salivary glands decrease drooling in children with neurologic impairments such as cerebral palsy, say researchers from Toronto's Hospital for Sick Children.

Generon commences F-627 Phase II trial in breast cancer

Generon Corporation Ltd. today announced the initiation of a Phase II clinical trial for F-627 after US FDA regulatory clearance. The current study is a Phase II, randomized, multicenter, open-label, active-controlled trial of F-627 in women with breast cancer receiving myelotoxic chemotherapy.

Walgreen agrees to pay $35 million to settle allegations of improper medication switches for Medicaid beneficiaries

Walgreen has agreed to pay $35 million to settle allegations that the company improperly switched the form of generic medications prescribed to Medicaid beneficiaries to receive higher reimbursements from the program, the Hartford Courant reports (Levick, Hartford Courant, 6/5).

Read more Medical News

› Verified 8 days ago

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9(current)